Cleared Special

WorkMate Claris System (K210392) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through the Special 510(k) pathway - typically does not require clinical trials.

K210392 · Abbott · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2021
Decision
29d
Days
Class 2
Risk

K210392 is an FDA 510(k) clearance for the WorkMate Claris System. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Abbott (St. Paul, US). The FDA issued a Cleared decision on March 11, 2021 after a review of 29 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Abbott devices

Submission Details

510(k) Number K210392 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 10, 2021
Decision Date March 11, 2021
Days to Decision 29 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
96d faster than avg
Panel avg: 125d · This submission: 29d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 183
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K210392.
HemoSphere Advanced Monitor, HemoSphere ClearSight Module, Acumen Hypotension Prediction Index
K203687 · Edwards Lifesciences, LLC · May 2021
Zio ECG Utilization Software (ZEUS) System
K202527 · iRhythm Technologies, Inc. · May 2021
Spacelabs Lifescreen PRO Analyzer
K201921 · Spacelabs Healthcare, Ltd. · Mar 2021
AltaTrack equipment, AltaTrack Guidewire, AltaTrack Catheter
K201081 · Philips Medical System Nederland B.V. · Dec 2020
Graffiti
K202189 · Ge Medical Systems Information Technologies, Inc. · Dec 2020
AcQMap High Resolution Imaging and Mapping System
K201015 · Acutus Medical, Inc. · Dec 2020